NEW YORK, Jan 19 – Third Wave Technologies is planning to test the IPO waters with a roadshow that is scheduled to begin next week, a company spokeswoman said Friday.

The company is hoping to sell 8.5 million shares at $11 - $13 a share in an offering that could raise as much as $110 million for the Madison, Wis.-based maker of SNP analysis technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.